Valeant shares slide on news of probe by U.S. SEC

(Reuters) - Shares in Valeant Pharmaceuticals International Inc fell as much as 21 percent on Monday after the embattled drugmaker revealed that it was under investigation by the U.S. Securities and Exchange Commision.


Read more